AcelRx Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.05.15	Pre-market Movers For May 14 (KSS, CSCO, CTRP, ACRX, SHAK, JCP, ISSI) (RTTNews)
05.05.15	Pre-market Movers For May 5 (DIS, DISCA, TSLA, GLNG, K, CONN, NFLX, DTV, ACRX) (RTTNews)
05.05.15	ACRX Deeply Pained, ISIS Cuts A Deal, AQXP Reaches Enrollment Target (RTTNews)
05.05.15	After-market Movers For May 4 (APC, THC, IM, CGNX, NUVA, ACRX, QLYS, RAIL) (RTTNews)
17.03.15	BDSI On Watch, Busy Months Ahead For LJPC, AQXP Awaits Leadership (RTTNews)
16.03.15	AcelRx Pharma Begins Pivotal Phase 3 Trial For ARX-04 - Quick Facts (RTTNews)
10.03.15	ACRX Plunges On Zalviso News, CTIC Persists, HTBX On Fire, PIP Cuts Head Count (RTTNews)
09.03.15	FDA Asks AcelRx For Additional Trial On Pain Drug - Quick Facts (RTTNews)
22.10.14	AcelRx Reports Publication Of Zalviso Phase 3 Abdominal Trial Results (RTTNews)
26.09.14	AcelRx Pharma Provides Update On Zalviso - Quick Facts (RTTNews)
26.07.14	AcelRx Pharma Receives Complete Response Letter From FDA For NDA For Zalviso (RTTNews)
07.07.14	Grunenthal Submits Marketing Authorization Application For ZALVISO To EMA (RTTNews)
24.06.14	NeoChord Names David Chung President And CEO - Quick Facts (RTTNews)
25.03.14	AcelRx Pharma Names Timothy Morris CFO - Quick Facts (RTTNews)
03.12.13	ACRX At FDA Altar, Orphan Drug Status Lifts CNAT, LCI Moves To NYSE (RTTNews)
02.12.13	AcelRx Says FDA Accepted Zalviso New Drug Application For Filing (RTTNews)
15.10.13	AcelRx Pharmaceuticals Announces Data Presentations for Zalviso™ at US and International Medical Meetings (PR Newswire)
08.10.13	AcelRx Pharmaceuticals Provides Update on its Patent Portfolio for Zalviso™ and its Proprietary Platform Technologies (PR Newswire)
01.10.13	ACRX Files Zalviso NDA, BGMD Gets A Booster, UK's NICE Turns Nice To PSDV (RTTNews)
30.09.13	AcelRx Pharmaceuticals Submits New Drug Application to the FDA for Zalviso™ (PR Newswire)
30.08.13	AcelRx Pharmaceuticals to Present at the Stifel Healthcare Conference 2013 (PR Newswire)
13.08.13	GALT Vaults, BIOD, CCXI, ESPR Await Q3 Catalysts, Watch Out For OSIR (RTTNews)
12.08.13	AcelRx Pharmaceuticals Reports Second Quarter 2013 Financial Results (PR Newswire)
05.08.13	AcelRx Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference (PR Newswire)
02.08.13	AcelRx Pharmaceuticals to Hold Second Quarter 2013 Financial Results Conference Call and Webcast on August 12, 2013 (PR Newswire)
23.07.13	AcelRx Pharmaceuticals Announces Closing Of Public Offering And Exercise Of Option To Purchase Additional Shares (PR Newswire)
18.07.13	AcelRx Pharma Prices Public Offering Of 3.8 Mln Shares At $11.65/shr (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu AcelRx Pharmaceuticals Inc.

Aktien Top/Flop

Meistgelesene Nachrichten